Institutional XRP Exposure: The Trend Is Getting Harder to Ignore
The filing adds Militia Capital to a rapidly expanding list of regulated investment firms with documented XRP exposure. An amended 13F signals that the firm updated a prior disclosure, and the XRP ETF position is now part of the official record.
A List That Keeps Growing
Militia Capital’s filing fits a pattern emerging in 2026. Multiple institutions have now disclosed XRP ETF positions through SEC filings, each one arriving independently and through different product structures.
Gallacher Capital Management reported 86,744 shares in the Canary XRP ETF at a value of $961,126 in its Q2 13F-HR. Brookstone Capital Management holds a disclosed XRP ETF position as well.
Citadel disclosed 34,900 call options on the Canary XRP ETF in a 13F filed earlier in 2026. The firm had closed its put options entirely. Bank of Montreal filed a Form 13F-HR for Q2 2026 on August 12, covering the period ending June 30.
Bitrue has also reported that Franklin Templeton clients purchased $5.66 million worth of XRP. The seven U.S. spot XRP ETFs have seen record-breaking performance this year, with cumulative net inflows in the billions.
The Bitwise Product
Militia Capital’s position sits specifically in the Bitwise XRP ETF. Bitwise has consistently led XRP ETF inflow data in 2026. On July 16, Bitwise recorded $4.41 million in a single day of net inflows, the highest of any XRP ETF product that day. Militia Capital’s 31,820 shares represent a deliberate allocation to the leading product by flow volume.
Regulated Exposure Through Compliant Vehicles
Each 13F represents a considered decision. Compliance teams approve these positions. Portfolio managers are allocating capital to XRP products. Militia Capital’s amended 13F shows that institutional interest and adoption of XRP are growing. BankXRP noted that “the trend is getting harder to ignore.” The filings support that assessment.
Hedge funds, asset managers, commercial banks, and now Militia Capital have each chosen regulated XRP ETF products as their vehicle of entry. The community pushed for the launch of spot XRP ETFs for years, and these products are paying off.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Rhythm Pharma EVP, Head of International Yann Mazabraud sells USD 6.61 million in common shares
Maxi Renda FII reports 567,206,273 issued units outstanding
BioXcel Therapeutics director Susan E. Atkins files initial beneficial ownership statement
